These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26044747)

  • 1. Treatment of Incidental Prostate Cancer by Active Surveillance: Results of the HAROW Study.
    Herden J; Eminaga O; Wille S; Weissbach L
    Urol Int; 2015; 95(2):209-15. PubMed ID: 26044747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active surveillance in localized prostate cancer: comparison of incidental tumours (T1a/b) and tumours diagnosed by core needle biopsy (T1c/T2a): results from the HAROW study.
    Herden J; Wille S; Weissbach L
    BJU Int; 2016 Aug; 118(2):258-63. PubMed ID: 26332209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active Surveillance for Incidental (cT1a/b) Prostate Cancer: Long-Term Outcomes of the Prospective Noninterventional HAROW Study.
    Herden J; Schwarte A; Boedefeld EA; Weissbach L
    Urol Int; 2021; 105(5-6):428-435. PubMed ID: 33517336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk stratification: a tool to predict the course of active surveillance for localized prostate cancer?
    Herden J; Heidenreich A; Weissbach L
    BJU Int; 2017 Aug; 120(2):212-218. PubMed ID: 27862832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Treatment of Localized Prostate Cancer in Everyday Practice in Germany.
    Herden J; Ansmann L; Ernstmann N; Schnell D; Weißbac L
    Dtsch Arztebl Int; 2016 May; 113(19):329-36. PubMed ID: 27232362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The HAROW study: an example of outcomes research: a prospective, non-interventional study comparing treatment options in localized prostate cancer].
    Herden J; Ernstmann N; Schnell D; Weißbach L
    Urologe A; 2014 Dec; 53(12):1743-52. PubMed ID: 25412911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative assessment of active surveillance for localized prostate cancer in the community versus tertiary care referral center.
    Becker A; Seiler D; Kwiatkowski M; Kluth LA; Schnell D; Graefen M; Schlomm T; Fisch M; Recker F; Weissbach L; Chun FK
    World J Urol; 2014 Aug; 32(4):891-7. PubMed ID: 24820259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Patterns of care of patients with localized prostate cancer in Germany: a health care study with focus on active surveillance].
    Chun FK; Becker A; Kluth LA; Seiler D; Schnell D; Fisch M; Graefen M; Weissbach L
    Urologe A; 2015 Jan; 54(1):6-13. PubMed ID: 25391440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active Surveillance for Prostate Cancer: Debate over the Application, Not the Concept.
    Klotz L
    Eur Urol; 2015 Jun; 67(6):1006-1008. PubMed ID: 25630451
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial Comment to Current use of active surveillance for localized prostate cancer: A nationwide survey in Japan.
    Van Bruwaene S; Murphy DG
    Int J Urol; 2015 Aug; 22(8):760. PubMed ID: 26147189
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of local prostate carcinoma. Questions answered by outcome research].
    Schnell D; Schön H; Weissbach L
    Urologe A; 2009 Sep; 48(9):1050-5. PubMed ID: 19693480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate biopsy decisions: one-size-fits-all approach with total PSA is out and a multivariable approach with the Prostate Health Index is in.
    Loeb S
    BJU Int; 2016 Mar; 117(3):383. PubMed ID: 26054000
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of Cigarette Smoking and Smoking Cessation with Biochemical Recurrence of Prostate Cancer in Patients Treated with Radical Prostatectomy.
    Rieken M; Shariat SF; Kluth LA; Fajkovic H; Rink M; Karakiewicz PI; Seitz C; Briganti A; Rouprêt M; Loidl W; Trinh QD; Bachmann A; Pourmand G
    Eur Urol; 2015 Dec; 68(6):949-56. PubMed ID: 26050111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary, supplement, and adipose tissue tocopherol levels in relation to prostate cancer aggressiveness among African and European Americans: The North Carolina-Louisiana Prostate Cancer Project (PCaP).
    Antwi SO; Steck SE; Su LJ; Hébert JR; Zhang H; Fontham ET; Smith GJ; Bensen JT; Mohler JL; Arab L
    Prostate; 2015 Sep; 75(13):1419-35. PubMed ID: 26053590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI factors to predict urinary incontinence after retropubic/laparoscopic radical prostatectomy.
    Tienza A; Hevia M; Benito A; Pascual JI; Zudaire JJ; Robles JE
    Int Urol Nephrol; 2015 Aug; 47(8):1343-9. PubMed ID: 26049974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Review of Decision Aids for Newly Diagnosed Patients with Prostate Cancer Making Treatment Decisions.
    Adsul P; Wray R; Spradling K; Darwish O; Weaver N; Siddiqui S
    J Urol; 2015 Nov; 194(5):1247-52. PubMed ID: 26055824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low testosterone level is an independent risk factor for high-grade prostate cancer detection at biopsy.
    Park J; Cho SY; Jeong SH; Lee SB; Son H; Jeong H
    BJU Int; 2016 Aug; 118(2):230-5. PubMed ID: 26086732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active surveillance for low-risk prostate cancer: Need for intervention and survival at 10 years.
    Preston MA; Feldman AS; Coen JJ; McDougal WS; Smith MR; Paly JJ; Carrasquillo R; Wu CL; Dahl DM; Barrisford GW; Blute ML; Zietman AI
    Urol Oncol; 2015 Sep; 33(9):383.e9-16. PubMed ID: 26059076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-Fluciclovine PET/CT for the Detection of Prostate Cancer Relapse: A Comparison to 11C-Choline PET/CT.
    Nanni C; Schiavina R; Brunocilla E; Boschi S; Borghesi M; Zanoni L; Pettinato C; Martorana G; Fanti S
    Clin Nucl Med; 2015 Aug; 40(8):e386-91. PubMed ID: 26053708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is supplemental external beam radiation therapy necessary for patients with higher risk prostate cancer treated with 103Pd? Results of two prospective randomized trials.
    Merrick GS; Wallner KE; Galbreath RW; Butler WM; Fiano R; Orio PF; Adamovich E
    Brachytherapy; 2015; 14(5):677-85. PubMed ID: 26051802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.